From the Globe and Mail:
A drug that needs to be injected only once a year can sharply reduce fractures in women suffering from the bone-weakening disease osteoporosis, according to a new study.
Annual treatment with zoledronic acid produced impressive results in a large clinical trial, including:
A 70-per-cent reduction in spine fractures;
A 41-per-cent drop in broken hips;
A 25-per-cent reduction in other fractures, such as broken wrists.
On the downside, the drug appears to increase the risk of atrial fibrillation, a heart condition that greatly increases the risk of stroke. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment